CD4 and cervical cancer: Since persistent HPV infection impairs Th1 cellular response to HPV, leading to cervical cancer progression11, 31, 32, 33, we investigated whether our DNA vaccine could drive the differentiation of HPV-specific CD4 T cells into Th1 effector cells.